Effectiveness of WBC reduction in neonates: what is the evidence of benefit? - Wikidata - awgldk - TriplyDB

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

http://www.wikidata.org/entity/Q34564936

about

A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia.Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.Resuscitation with washed aged packed red blood cell units decreases the proinflammatory response in mice after hemorrhage.Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.Reducing the risk of transfusion-transmitted cytomegalovirus infection: a systematic review and meta-analysis.Reducing costs in flow-cytometric counting of residual white blood cells in blood products: utilization of a single-platform bead-free flow-rate calibration method.

P2860

Q33376796-19B06842-811D-40E5-8D5D-FB612F893EB3 Q33404815-89FB60E5-079A-4F29-B482-6E95B3614FFE Q36182125-2E39CB38-0414-4E75-841A-D8321D297966 Q37323823-C94CF449-23F6-4F78-ADCD-042E10579492 Q38716452-D5BFF62E-7AD0-42AA-A24A-4E0218248B6D Q50549313-EE141D86-5014-424F-AF3C-1F4CF40EA4A8

P2860

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

http://www.wikidata.org/entity/Q34564936

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@ast

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@en

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@nl

type

label

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@ast

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@en

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@nl

prefLabel

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@ast

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@en

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@nl

P1433

Q34564936-01FC5F5D-0A7C-4170-B403-E3FFC9F202E2

P1476

Q34564936-3867F095-565D-4A51-A680-D533D0414F03

P2093

Q34564936-18125FC9-9100-4605-B8A9-15310F6ED62C

Q34564936-28995B61-024E-48DE-8109-EE456B52EDA6

Q34564936-AA2E824C-E397-49EA-879E-6DB453B97E29

Q34564936-EE69132E-EB43-49BA-A969-2195ED8F2BF5

P2860

Q34564936-1073C337-D58C-432B-AE30-A5180F84FCCE

Q34564936-234AF6A2-0FEA-4528-91E3-14B0173E7613

Q34564936-3753FFA2-4B6F-4539-9A67-B0805ECA6FD4

Q34564936-4E9AA30C-FB45-4978-979B-4CF7914F9BEF

Q34564936-67A3A3DC-FAA0-4376-92F6-845E62E1E6E8

Q34564936-70E25F71-E7B3-44C9-AAF1-265CA440A8CA

Q34564936-7882627B-4790-48E6-AC6B-9E56DCC15C02

Q34564936-8FA48641-C84E-4920-8467-B795E19CAB05

Q34564936-99111714-ED60-4E8A-8711-3C89345D9C67

Q34564936-DCC7CDAB-B91D-4432-BC8F-2E3C4794DFB7

P304

Q34564936-793DDCAF-1CE4-4749-8DDC-EC4623AAAC22

P31

Q34564936-68DEA015-934D-44A6-A728-C5B56823DB3F

P356

Q34564936-A6E34ACA-2779-4A32-BB50-9A2638616C49

P433

Q34564936-95F5A01D-51CB-497A-A302-24EB396BED80

P478

Q34564936-70B00C00-737C-430E-8E0B-DF6FABF6B4E7

P577

Q34564936-2443225F-8C62-414A-BA55-E5CCCA9A6624

P698

Q34564936-28176F98-0082-4266-A00D-6584F3653A3E

P356

J.1537-2995.2002.00022.X

P1433

P1476

Effectiveness of WBC reduction in neonates: what is the evidence of benefit?

@en

P2093

Dean Fergusson

http://www.w3.org/2001/XMLSchema#string

Keith J Barrington

http://www.w3.org/2001/XMLSchema#string

Paul C Hébert

http://www.w3.org/2001/XMLSchema#string

Stanley H Shapiro

http://www.w3.org/2001/XMLSchema#string

P2860

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.

A survey of Canadian neonatal blood transfusion practices.

Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

The cellular prion protein binds copper in vivo.

Reducing the risk for transfusion-transmitted cytomegalovirus infection.

Improved renal allograft survival after blood transfusion: a nonspecific, erythrocyte-mediated immunoregulatory process?

Efficacy of leukocyte filters in the bypass circuit for infants undergoing cardiac operations.

Immune response to blood transfusion invery-low-birthweight infants.

The development of anti-HLA antibodies in multiply transfused preterm infants

Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood.

P304

159-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1537-2995.2002.00022.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11896329

http://www.w3.org/2001/XMLSchema#string